Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy.
Cusato J, Boglione L, De Nicolò A, Caviglia GP, Mornese Pinna S, Ciancio A, Troshina G, Smedile A, Antonucci M, Avataneo V, Palermiti A, Mula J, Manca A, Cariti G, Cantù M, Saracco GM, Di Perri G, D'Avolio A. Cusato J, et al. Among authors: ciancio a. Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355. Pharmaceuticals (Basel). 2022. PMID: 35337152 Free PMC article.
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
Saracco G, Ciancio A, Olivero A, Smedile A, Roffi L, Croce G, Colletta C, Cariti G, Andreoni M, Biglino A, Calleri G, Maggi G, Tappero GF, Orsi PG, Terreni N, Macor A, Di Napoli A, Rinaldi E, Ciccone G, Rizzetto M. Saracco G, et al. Among authors: ciancio a. Hepatology. 2001 Jul;34(1):133-8. doi: 10.1053/jhep.2001.25636. Hepatology. 2001. PMID: 11431744 Clinical Trial.
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.
Saracco G, Olivero A, Ciancio A, Carenzi S, Smedile A, Cariti G, Andreoni M, Orsi PG, Biglino A, Tabone M, Roffi L, Croce G, Manca A, Tappero G, Ciccone G, Rizzetto M. Saracco G, et al. Among authors: ciancio a. Hepatology. 2002 Oct;36(4 Pt 1):959-66. doi: 10.1053/jhep.2002.35442. Hepatology. 2002. PMID: 12297844 Clinical Trial.
Therapy of chronic hepatitis C: a critical review.
Saracco G, Olivero A, Ciancio A, Carenzi S, Rizzetto M. Saracco G, et al. Among authors: ciancio a. Curr Drug Targets Infect Disord. 2003 Mar;3(1):25-32. doi: 10.2174/1568005033342127. Curr Drug Targets Infect Disord. 2003. PMID: 12570730 Review.
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?
Ciancio A, Smedile A, Giordanino C, Colletta C, Croce G, Pozzi M, Cariti G, Macor A, Biglino A, Di Napoli A, Tappero GF, Andreoni M, Manca A, Prandi G, Calleri G, Orsi PG, Ciccone G, Rizzetto M, Saracco G; North West Italian Hepatologic Group. Ciancio A, et al. Am J Gastroenterol. 2006 Aug;101(8):1811-6. doi: 10.1111/j.1572-0241.2006.00669.x. Epub 2006 Jun 16. Am J Gastroenterol. 2006. PMID: 16780556 Clinical Trial.
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.
Ciancio A, Picciotto A, Giordanino C, Smedile A, Tabone M, Manca A, Marenco G, Garbagnoli P, Andreoni M, Cariti G, Calleri G, Sartori M, Cusumano S, Grasso A, Rizzi R, Gallo M, Basso M, Anselmo M, Percario G, Ciccone G, Rizzetto M, Saracco G. Ciancio A, et al. Aliment Pharmacol Ther. 2006 Oct 1;24(7):1079-86. doi: 10.1111/j.1365-2036.2006.03098.x. Aliment Pharmacol Ther. 2006. PMID: 16984502 Clinical Trial.
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
Giordanino C, Bugianesi E, Smedile A, Ciancio A, Abate ML, Olivero A, Pellicano R, Cassader M, Gambino R, Bo S, Ciccone G, Rizzetto M, Saracco G. Giordanino C, et al. Among authors: ciancio a. Am J Gastroenterol. 2008 Oct;103(10):2481-7. doi: 10.1111/j.1572-0241.2008.02002.x. Epub 2008 Aug 8. Am J Gastroenterol. 2008. PMID: 18702647 Clinical Trial.
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.
D'Avolio A, Ciancio A, Siccardi M, Baietto L, Simiele M, Cariti G, Calcagno A, Smedile A, Cusato J, Bonora S, Rizzetto M, Di Perri G. D'Avolio A, et al. Among authors: ciancio a. Hepatology. 2011 Dec;54(6):2278-9. doi: 10.1002/hep.24636. Hepatology. 2011. PMID: 21898489 No abstract available.
249 results